These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21670437)

  • 1. Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies.
    Cappelletti C; Baggi F; Zolezzi F; Biancolini D; Beretta O; Severa M; Coccia EM; Confalonieri P; Morandi L; Mora M; Mantegazza R; Bernasconi P
    Neurology; 2011 Jun; 76(24):2079-88. PubMed ID: 21670437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
    Gherardi RK
    Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.
    de Padilla CM; Reed AM
    Curr Opin Rheumatol; 2008 Nov; 20(6):669-74. PubMed ID: 18946326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.
    Bhattarai S; Ghannam K; Krause S; Benveniste O; Marg A; de Bruin G; Xin BT; Overkleeft HS; Spuler S; Stenzel W; Feist E
    J Autoimmun; 2016 Dec; 75():118-129. PubMed ID: 27522114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy, inflammation and innate immunity in inflammatory myopathies.
    Cappelletti C; Galbardi B; Kapetis D; Vattemi G; Guglielmi V; Tonin P; Salerno F; Morandi L; Tomelleri G; Mantegazza R; Bernasconi P
    PLoS One; 2014; 9(11):e111490. PubMed ID: 25365350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.
    Rothwell S; Cooper RG; Lundberg IE; Miller FW; Gregersen PK; Bowes J; Vencovsky J; Danko K; Limaye V; Selva-O'Callaghan A; Hanna MG; Machado PM; Pachman LM; Reed AM; Rider LG; Cobb J; Platt H; Molberg Ø; Benveniste O; Mathiesen P; Radstake T; Doria A; De Bleecker J; De Paepe B; Maurer B; Ollier WE; Padyukov L; O'Hanlon TP; Lee A; Amos CI; Gieger C; Meitinger T; Winkelmann J; Wedderburn LR; Chinoy H; Lamb JA;
    Ann Rheum Dis; 2016 Aug; 75(8):1558-66. PubMed ID: 26362759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
    Kim H; Gunter-Rahman F; McGrath JA; Lee E; de Jesus AA; Targoff IN; Huang Y; O'Hanlon TP; Tsai WL; Gadina M; Miller FW; Goldbach-Mansky R; Rider LG
    Arthritis Res Ther; 2020 Apr; 22(1):69. PubMed ID: 32252809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.
    Preuße C; Allenbach Y; Hoffmann O; Goebel HH; Pehl D; Radke J; Doeser A; Schneider U; Alten RH; Kallinich T; Benveniste O; von Moers A; Schoser B; Schara U; Stenzel W
    Acta Neuropathol Commun; 2016 Apr; 4(1):45. PubMed ID: 27121733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
    Suárez-Calvet X; Gallardo E; Nogales-Gadea G; Querol L; Navas M; Díaz-Manera J; Rojas-Garcia R; Illa I
    J Pathol; 2014 Jul; 233(3):258-68. PubMed ID: 24604766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cDNA microarrays reveal distinct gene expression clusters in idiopathic inflammatory myopathies.
    Zhou X; Dimachkie MM; Xiong M; Tan FK; Arnett FC
    Med Sci Monit; 2004 Jul; 10(7):BR191-7. PubMed ID: 15232492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease.
    Sun WC; Sun YC; Lin H; Yan B; Shi GX
    Br J Dermatol; 2012 Dec; 167(6):1236-44. PubMed ID: 23013528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis of juvenile dermatomyositis.
    Khanna S; Reed AM
    Muscle Nerve; 2010 May; 41(5):581-92. PubMed ID: 20405498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated type I IFN signalling directly affects CD8
    Huang B; Li H; Jiang Q; Li Y; Jiang Z; Cao H; Wang S; Wang X; Li J; Li G
    J Autoimmun; 2024 Jun; 146():103232. PubMed ID: 38692172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myogenic Progenitor Cells Exhibit Type I Interferon-Driven Proangiogenic Properties and Molecular Signature During Juvenile Dermatomyositis.
    Gitiaux C; Latroche C; Weiss-Gayet M; Rodero MP; Duffy D; Bader-Meunier B; Glorion C; Nusbaum P; Bodemer C; Mouchiroud G; Chelly J; Germain S; Desguerre I; Chazaud B
    Arthritis Rheumatol; 2018 Jan; 70(1):134-145. PubMed ID: 28941175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytokines and chemokines in idiopathic inflammatory myopathies.
    De Paepe B; Creus KK; De Bleecker JL
    Curr Opin Rheumatol; 2009 Nov; 21(6):610-6. PubMed ID: 19726994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection.
    Musumeci G; Castrogiovanni P; Barbagallo I; Tibullo D; Sanfilippo C; Nunnari G; Pellicanò GF; Pavone P; Caltabiano R; Di Marco R; Imbesi R; Di Rosa M
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients.
    Higgs BW; Zhu W; Morehouse C; White WI; Brohawn P; Guo X; Rebelatto M; Le C; Amato A; Fiorentino D; Greenberg SA; Drappa J; Richman L; Greth W; Jallal B; Yao Y
    Ann Rheum Dis; 2014 Jan; 73(1):256-62. PubMed ID: 23434567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.
    Haq SA; Tournadre A
    Int J Rheum Dis; 2015 Nov; 18(8):818-25. PubMed ID: 26385431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies.
    Hou C; Durrleman C; Periou B; Barnerias C; Bodemer C; Desguerre I; Quartier P; Melki I; Rice GI; Rodero MP; Charuel JL; Relaix F; Bader-Meunier B; Authier F; Gitiaux C
    Arthritis Rheumatol; 2021 Jun; 73(6):1044-1052. PubMed ID: 33314705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.
    Kim GT; Cho ML; Park YE; Yoo WH; Kim JH; Oh HJ; Kim DS; Baek SH; Lee SH; Lee JH; Kim HY; Kim SI
    Clin Rheumatol; 2010 Mar; 29(3):273-9. PubMed ID: 19953283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.